Fecal Microbial Transplantation in Critically Ill Patients With Severe Infections.
Status:
Not yet recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
Fecal microbial transplantation is to transplant functional microbiota from the feces of
healthy people into the gastrointestinal tract of patients, reconstruct new intestinal
microbiota, and realize the treatment of intestinal and extra-intestinal diseases. Compared
with ordinary commercial probiotics, FMT is more consistent with the composition of the
intestinal microecological structure and can recover intestinal flora to the maximum extent
and faster. FMT increases intestinal bacteria production function and helps to restore the
systemic immune response so that sepsis pathogens are removed. The aim of this trial was to
investigate the clinical effect of FMT in the treatment of patients with severe infections.